These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12861975)

  • 1. Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA.
    Smee D
    IDrugs; 2003 Jun; 6(6):518-21. PubMed ID: 12861975
    [No Abstract]   [Full Text] [Related]  

  • 2. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C Viruses and Biologics.
    Grewal P; Sanghera R
    Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
    Buti M
    IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-based and animal models for hepatitis B and C viruses.
    Schinazi RF; Ilan E; Black PL; Yao X; Dagan S
    Antivir Chem Chemother; 1999 May; 10(3):99-114. PubMed ID: 10431609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon].
    Tamori A; Kawada N
    Nihon Rinsho; 2012 Apr; 70(4):620-4. PubMed ID: 22568143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Asselah T; Marcellin P
    Liver Int; 2015 Jan; 35 Suppl 1():1-3. PubMed ID: 25529080
    [No Abstract]   [Full Text] [Related]  

  • 9. A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
    Shakya N; Vedi S; Liang C; Agrawal B; Tyrrell DL; Kumar R
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6475-80. PubMed ID: 22985854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18th International Conference on Antiviral Research. Antivirals.
    Kibble A
    IDrugs; 2005 Jun; 8(6):461-4. PubMed ID: 15906187
    [No Abstract]   [Full Text] [Related]  

  • 11. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
    Potthoff A; Berg T; Wedemeyer H;
    Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virology of hepatitis B and C viruses and antiviral targets.
    Pawlotsky JM
    J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy targeting viral polymerase.
    Tsai CH; Lee PY; Stollar V; Li ML
    Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis at a crossroad.
    Lok AS; Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
    [No Abstract]   [Full Text] [Related]  

  • 15. Designing a low-cost drug resistance database for viral hepatitis.
    Kuiken C
    Antivir Ther; 2010; 15(3 Pt B):517-20. PubMed ID: 20516573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis B and C virus antiviral resistance].
    Sáez-López A; Agüero-Balbín J
    Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):576-84. PubMed ID: 17125678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in antiviral agents: antiviral drug discovery for hepatitis viruses.
    Tanikawa K
    Curr Pharm Des; 2006; 12(11):1371-7. PubMed ID: 16611121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.
    Korba BE; Montero AB; Farrar K; Gaye K; Mukerjee S; Ayers MS; Rossignol JF
    Antiviral Res; 2008 Jan; 77(1):56-63. PubMed ID: 17888524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro anti-hepatitis B and C virus activities of ring-expanded ('fat') nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system.
    Zhang P; Zhang N; Korba BE; Hosmane RS
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5397-401. PubMed ID: 16213713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.